Similar articles

• All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy.

  Greenberg B, Mehra MR. Greenberg B, et al. Circulation. 2006 Dec 12;114(24):2685-90; discussion 2691. doi: 10.1161/CIRCULATIONAHA.104.514190. Circulation. 2006. PMID: 17159074 No abstract available.
• Cardiac function tests in neuromuscular diseases.

  Bhakta D, Groh WJ. Bhakta D, et al. Neurol Clin. 2004 Aug;22(3):591-617, vi. doi: 10.1016/j.ncl.2004.03.001. Neurol Clin. 2004. PMID: 15207877 Review.
• Cardiac resynchronization therapy--who benefits? Separating myths from facts.

  Deshpande S, Tol S, Lokhandwala Y. Deshpande S, et al. Indian Heart J. 2007 Jan-Feb;59(1 Suppl A):A57-62. Indian Heart J. 2007. PMID: 19104133 Review. No abstract available.
• The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Rhythm Association survey.

  Fumagalli S, Chen J, Dobreanu D, Madrid AH, Tilz R, Dagres N. Fumagalli S, et al. Europace. 2016 Apr;18(4):623-7. doi: 10.1093/europace/euw090. Europace. 2016. PMID: 27174994
• Advanced heart failure and transplant cardiology as a single subspecialty may restrict access to care.

  Jordan LW. Jordan LW. J Am Coll Cardiol. 2009 Aug 18;54(8):743; author reply 743-4. doi: 10.1016/j.jacc.2009.03.075. J Am Coll Cardiol. 2009. PMID: 19679256 No abstract available.